Drug Therapy

Contributing journals to this collection:
JAMA & Archives Journals

Citations 391-400 of 3664 total displayed.

Past content

Correspondence
Efalizumab and Progression of Undiagnosed Follicular Mycosis Fungoides—Reply

Sophie M. Worobec
Arch Dermatol 2009; 145: 844. [Extract] [Full text] [PDF]  

Clinical Sciences
Modalities to Decrease Stromal Herpes Simplex Keratitis Reactivation Rates

John D. Sheppard; Michael L. Wertheimer; Stephen V. Scoper
Arch Ophthalmol 2009; 127: 852-856. [Abstract] [Full text] [PDF]  

Original Contributions
Frequency, Characteristics, and Risk Factors for Amiodarone Neurotoxicity

Carolyn F. Orr; J. Eric Ahlskog
Arch Neurol 2009; 66: 865-869. [Abstract] [Full text] [PDF]  

Laboratory Sciences
Amelioration of Murine Dry Eye Disease by Topical Antagonist to Chemokine Receptor 2

Sunali Goyal; Sunil K. Chauhan; Qiang Zhang; Reza Dana
Arch Ophthalmol 2009; 127: 882-887. [Abstract] [Full text] [PDF]  

Images in Neurology
Vein of Galen Aneurysmal Malformation Treated With Onyx

Panagiotis Papanagiotou; Tilman Rohrer; Iris Q. Grunwald; Maria Politi; Ludwig Gortner; Wolfgang Reith
Arch Neurol 2009; 66: 906-907. [Extract] [Full text] [PDF]  

Editorials
Medication Costs Matter

Alan R. Morse
Arch Ophthalmol 2009; 127: 929-931. [Extract] [Full text] [PDF]  

Research Letters
Evaluating Patient Discomfort, Anxiety, and Fear Before and After Ranibizumab Intravitreous Injection for Wet Age-Related Macular Degeneration

Paul Yih Seng Chua; Izabela Mitrut; Ana-Marie Armbrecht; Archana Vani; Tariq Aslam; Baljean Dhillon
Arch Ophthalmol 2009; 127: 939-940. [Extract] [Full text] [PDF] [ eFigure ]  

Research Letters
Transconjunctival Orbital Invasion by Methicillin-Resistant Staphylococcus aureus

Sandra M. Brown; Gary T. Raflo; W. Lee Fanning
Arch Ophthalmol 2009; 127: 941-942. [Extract] [Full text] [PDF]  

Medical News & Perspectives
FDA Tells Drug and Device Makers to Give Balanced Picture of Risks in Ads, Labels

Bridget M. Kuehn
JAMA 2009; 301: 2541. [Extract] [Full text] [PDF]  

Health Agencies Update
Erlotinib Warning

Bridget M. Kuehn
JAMA 2009; 301: 2542-b. [Extract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367